Search for content, post, videos

Category

Intellectual Property

legal-advice
0 COMMENT
116 Views
SCA wins US Supreme Court Victory

SCA won an important victory before the United States Supreme Court on March 21, 2017 in its seven-year patent infringement case against First Quality Products, Inc. In a 7-1 decision written by Justice Alito, the Supreme Court concluded that the six-year statutory period of limitations during which a patent infringement…

lars-hedbys
0 COMMENT
233 Views
Idogen’s technology granted European patent

Idogen announces that the European Patent Office will formally grant a patent application, covering the company’s tolerogenic vaccine technology. The EPO approval strengthens the company’s patent portfolio for the vaccine technology. A patent in the same patent family has already been granted in Japan and a Notice of Allowance has…

peter_z_index_pharma
0 COMMENT
97 Views
InDex Pharmaceuticals granted patent in the US

InDex Pharmaceuticals Holding announces that a patent covering 19 compounds from the company’s DIMS platform has been granted by the United States Patent and Trademark Office (USPTO). InDex has a discovery stage portfolio of more than 150 DNA-based ImmunoModulatory Sequences (DIMS), several of which are already protected by approved composition-of-matter…

lars-hedbys-idogen
0 COMMENT
85 Views
Idogen reaches formal granting of patent in Japan

Idogen has announced that the Japan Patent Office (“JPO”) has granted the company’s patent application. The patent provides Idogen’s vaccine technology with a broad protection and further strengthens the company’s patent portfolio in an important market. The Japan Patent Office has now formally granted Idogen’s Patent Application covering induction of…

aldgate-tower
0 COMMENT
91 Views
EU patent court to open in December

The new Europe’s Unified Patent Court, partly based in London, is expected to open in December this year. The UPC Preparatory Committee has said that it is working ‘under the assumption’ that the court will become operational before the end of year – with a targeted opening date of 1…

targovax board of directors
0 COMMENT
94 Views
Targovax granted European Patent for ONCOS-102

Targovax announces the grant of European Patent no 2,379,586. This composition of matter patent protects Targovax’s lead product from its ONCOS platform, the oncolytic viral product ONCOS-102 and expires in 2029. A US patent covering ONCOS-102 was granted in May 2016. Targovax’s proprietary ONCOS platform generates novel oncolytic viruses, an…

christina_herder
0 COMMENT
96 Views
Dilaforette change name and announces IPO

Dilaforette Holding AB, a clinical-stage drug development and Karolinska Development portfolio company, announces its name change to Modus Therapeutics Holding AB and its intention to undertake an Initial Public Offering (IPO). A rights issue is planned in connection with the IPO in order to finance the further clinical development of the…

mikael oredsson bioinvent
0 COMMENT
77 Views
BioInvent expands patent approvals

BioInvent International announces that it has been granted additional patent protection in Japan, Russia and China for BI-505, its lead immune-oncology programme currently in Phase II for the treatment of multiple myeloma. These patents cover the use of BI-505 in the treatment of patients previously treated for cancer that have…